Quality-of-life outcomes and toxicity profile among patients with localized prostate cancer after radical prostatectomy treated with stereotactic body radiation: the scimitar multicenter phase 2 trial

HIGHLIGHTS

  • who: Ting Martin Ma MD and PhD from the Department of Radiation Oncology, University of California, Los Angeles, California have published the research work: Quality-of-Life Outcomes and Toxicity Profile Among Patients With Localized Prostate Cancer After Radical Prostatectomy Treated With Stereotactic Body Radiation: The SCIMITAR Multicenter Phase 2 Trial, in the Journal: (JOURNAL)
  • what: The aim of this study was to evaluate short-term physician-scored genitourinary (GU) and gastrointestinal (GI) toxicities and patientreported outcomes after postprostatectomy SBRT. This multicenter phase 2 study was designed to evaluate postprostatectomy SBRT with prostate bed doses . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?